Crinetics Pharmaceuticals, Inc.
(CRNX - NASDAQ)
38,60 USD
📋 Profilo Aziendale

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors.

|